Cellebrite (CLBT) shares surged 5.08% in pre-market trading on Thursday following the release of its impressive second-quarter 2025 financial results, the announcement of a new CEO, and an optimistic future outlook. The digital intelligence solutions provider demonstrated robust growth across key financial metrics, surpassing analyst expectations in several areas.

For Q2 2025, Cellebrite reported revenue of $113.276 million, an 18% year-over-year increase that beat the IBES estimate of $112.2 million. The company's subscription revenue saw a significant 21% rise to $103.0 million, while Annual Recurring Revenue (ARR) grew by 21% to $418.9 million. Adjusted EBITDA came in at $27.885 million, also surpassing the IBES estimate of $27 million, with an impressive margin of 24.6%.

Adding to the positive news, Cellebrite announced the appointment of Thomas E. Hogan as its new CEO. Hogan, who had been serving as interim CEO since January, expressed confidence in the company's growth trajectory and its ability to support customers in law enforcement, defense, and intelligence sectors. The combination of strong financial performance and new leadership appears to have bolstered investor confidence.

Looking ahead, Cellebrite provided an encouraging outlook for Q3 and full-year 2025. The company expects Q3 revenue between $121 million and $126 million, with adjusted EBITDA ranging from $31 million to $34 million. For the full year, Cellebrite projects revenue between $465 million and $475 million, with adjusted EBITDA expected to be between $118 million and $123 million. These projections, along with the company's ongoing expansion in the digital investigation market, seem to have further fueled investor optimism, contributing to the significant pre-market stock price increase.